Healthcare Realty Trust Reports Results for the First Quarter
Healthcare Realty Trust reported a net income of $42.2 million or $0.28 per diluted share for Q1 2022, with a normalized FFO of $64.8 million or $0.43 per share, representing a 3.6% increase year-over-year. The company acquired nine medical office buildings for $223.2 million, expanding its presence in key markets like Dallas and San Francisco. With a tenant retention rate of 83.5% and portfolio leasing activity totaling 501,000 square feet, Healthcare Realty continues to strengthen its position in the healthcare real estate sector.
- Net income of $42.2 million for Q1 2022.
- Normalized FFO per share increased by 3.6% to $0.43.
- Same store cash NOI grew 2.9% year-over-year.
- Acquired nine medical office buildings for $223.2 million.
- Tenant retention rate of 83.5%.
- Net debt to adjusted EBITDA ratio stands at 5.6 times.
- Dividend payments accounted for 82.2% of FAD.
NASHVILLE, Tenn., May 05, 2022 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the first quarter ended March 31, 2022. The Company reported net income of
Salient quarterly highlights include:
- Normalized FFO per share totaled
$0.43 , an increase of3.6% from$0.42 in the first quarter of 2021. - Same store cash NOI for the first quarter increased
2.9% over the prior year. For the trailing twelve months ended March 31, 2022, same store cash NOI grew2.6% . - Predictive growth measures in the same store portfolio include:
- Average in-place rent increases of
2.94% - Future annual contractual increases of
3.0% for leases commencing in the quarter - Weighted average cash leasing spreads of
3.4% on 260,000 square feet renewed:2% (<0% spread)7% (0-3% )76% (3-4% )15% (>4% )
- Tenant retention of
83.5%
- Average in-place rent increases of
- Portfolio leasing activity in the first quarter totaled 501,000 square feet related to 167 leases:
- 318,000 square feet of renewals
- 183,000 square feet of new and expansion leases
- During the first quarter, the Company acquired nine medical office buildings for
$223.2 million totaling 399,000 square feet.- In Dallas, a medical office building for
$8.2 million totaling 18,000 square feet adjacent to Aa2 rated Texas Health's Harris Methodist Hospital. The Company now owns three properties in this cluster and 2.3 million square feet in the Dallas market. - In San Francisco, six buildings totaling 277,000 square feet associated with multiple, investment grade rated health systems for
$181.2 million .- Three buildings totaling 166,000 square feet for
$114.0 million consisting of a 25,000 square foot building anchored by AA- rated Kaiser Permanente, a 77,000 square foot building anchored by A rated Sutter Health, and a 65,000 square foot building anchored by A rated Sutter Health and A- rated CommonSpirit Health. - Three buildings totaling 111,000 square feet for
$67.2 million consisting of a 45,000 square foot on-campus building leased to BBB rated MarinHealth, a 42,000 square foot building located adjacent to AA- rated Kaiser's Santa Rosa Medical Center, and a 23,000 square foot building anchored by A rated Sutter Health. The investments were made in the TIAA joint venture. - The Company now has investments in nine buildings totaling 564,000 square feet in the San Francisco market.
- Three buildings totaling 166,000 square feet for
- In Dallas, a medical office building for
- In Los Angeles, two buildings for
$33.8 million totaling 103,000 square feet and located near the Valley Presbyterian Hospital. The investment was made in the TIAA joint venture. The Company has investments in 22 buildings with over 1.3 million square feet in the Los Angeles market.
- Subsequent to the end of the first quarter, the Company acquired eight medical office buildings totaling 219,000 square feet for
$117.6 million .- In Atlanta, a 22,000 square foot building for
$6.9 million on the campus of A2 rated Wellstar Health's Douglas Hospital. The Company now owns six buildings on this campus totaling 158,000 square feet. - In Colorado Springs, two medical office buildings totaling 26,000 square feet for
$13.7 million leased to a diverse mix of tenants. The Company now owns five buildings in this cluster totaling 191,000 square feet. - In Denver, a 12,000 square foot building for
$6.3 million anchored by A- rated CommonSpirit Health. The Company now owns three buildings in this cluster totaling 88,000 square feet. - In Houston, a 77,000 square foot building for
$36.3 million leased to a diverse mix of tenants. The Company now owns eight buildings in this cluster totaling 516,000 square feet. - In Los Angeles, a 34,000 square foot building and a parking garage for
$35.0 million adjacent to AA- rated Cedars-Sinai's Huntington Hospital. The Company now owns four buildings in this cluster totaling 200,000 square feet. - In Oklahoma City, a 35,000 square foot building for
$11.1 million adjacent to A+ rated Mercy Health's Oklahoma City Hospital. The Company now owns four buildings in this market totaling 215,000 square feet. - In Seattle, a 13,000 square foot building for
$8.4 million adjacent to AA+ rated UW Medicine's Valley Medical Center. The Company now owns five buildings in this cluster totaling 331,000 square feet.
- In Atlanta, a 22,000 square foot building for
- During the first quarter, the Company settled 0.7 million shares through its forward equity program, generating
$22.3 million in net proceeds. - Net debt to adjusted EBITDA was 5.6 times at the end of the quarter.
- A dividend of
$0.31 per share was paid during the quarter, which equaled82.2% of FAD. For the trailing twelve months, dividends paid equaled88.4% of FAD. - A dividend of
$0.31 per share is payable on May 27, 2022 for stockholders of record on May 16, 2022.
Strategic transaction update:
- On February 28, 2022, the Company announced an
$18 billion strategic combination with Healthcare Trust of America ("HTA"), creating the preeminent medical office building REIT. - The Company and HTA have received letters of intent from, and are in advanced negotiations with, three institutional investors for a combination of joint venture and asset sales totaling
$1.7 billion at a weighted average cap rate of4.8% . Net proceeds from these transactions are expected to be approximately$1.6 billion . The transactions may occur in separate tranches, with the initial transactions expected to close prior to the vote on the merger by the Company and HTA stockholders and the remainder to be completed on or around the closing date of the merger. These transactions are subject to execution of definitive documentation and customary closing conditions. - The Company and HTA have secured commitments for amended and restated credit facilities, including the following components:
- a
$1.5 billion revolving credit facility; $1.5 billion of term loans, including$650 million of new capacity; and- a
$1.1 billion term asset sale loan to replace the transaction bridge loan commitment and to backstop the$1.1 billion special cash dividend to HTA shareholders, if needed, depending on the timing of asset sales and joint ventures.
- a
- Immediately following the transaction closing, the Company expects to combine the surviving Healthcare Realty subsidiary with HTA's existing operating partnership to maintain the UPREIT structure going forward. The UPREIT structure will align the combined company's unsecured debt obligations in the operating partnership and provide tax efficient strategies for future acquisitions.
- On May 2, 2022, the Company and HTA filed a preliminary joint merger proxy with the Securities and Exchange Commission ("SEC"). Assuming a customary SEC review timeline, the Company and HTA expect to hold separate special shareholder meetings on or about the same date in early to mid-July for shareholders of record to vote on the merger. The closing of the merger is expected to follow shortly thereafter.
- On May 3, 2022, the Company’s Board of Directors authorized the repurchase of up to
$500.0 million of outstanding shares of the Company’s common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints, and other customary conditions.
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of March 31, 2022, the Company was invested in 263 real estate properties in 23 states totaling 17.9 million square feet and had an enterprise value of approximately
Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. Please contact the Company at 615.269.8175 to request a printed copy of this information.
In addition to the historical information contained within, the matters discussed in this press release may contain forward-looking statements that involve risks and uncertainties. These risks are discussed in filings with the Securities and Exchange Commission by Healthcare Realty Trust, including its Annual Report on Form 10-K for the year ended December 31, 2021 under the heading "Risk Factors," and other risks described from time to time thereafter in the Company's SEC filings. Forward-looking statements represent the Company's judgment as of the date of this release. The Company disclaims any obligation to update forward-looking statements. A reconciliation of all non-GAAP financial measures in this release is included herein.
Consolidated Balance Sheets 1 |
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA |
ASSETS | |||||||
MARCH 31, 2022 | DECEMBER 31, 2021 | ||||||
Real estate properties | |||||||
Land | |||||||
Buildings, improvements and lease intangibles | 4,533,583 | 4,458,119 | |||||
Personal property | 11,639 | 11,761 | |||||
Investment in financing receivables, net | 112,515 | 186,745 | |||||
Financing lease right-of-use assets | 71,966 | 31,576 | |||||
Construction in progress | 7,319 | 3,974 | |||||
Land held for development | 22,950 | 24,849 | |||||
Total real estate investments | 5,187,394 | 5,104,942 | |||||
Less accumulated depreciation and amortization | (1,351,796 | ) | (1,338,743 | ) | |||
Total real estate investments, net | 3,835,598 | 3,766,199 | |||||
Cash and cash equivalents | 22,694 | 13,175 | |||||
Assets held for sale, net | 14,961 | 57 | |||||
Operating lease right-of-use assets | 126,851 | 128,386 | |||||
Investments in unconsolidated joint ventures | 211,195 | 161,942 | |||||
Other assets, net | 199,186 | 189,160 | |||||
Total assets | |||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
MARCH 31, 2022 | DECEMBER 31, 2021 | ||||||
Liabilities | |||||||
Notes and bonds payable | |||||||
Accounts payable and accrued liabilities | 69,131 | 86,108 | |||||
Liabilities of properties held for sale | 687 | 294 | |||||
Operating lease liabilities | 94,636 | 96,138 | |||||
Financing lease liabilities | 61,732 | 22,551 | |||||
Other liabilities | 63,979 | 67,387 | |||||
Total liabilities | 2,197,603 | 2,073,803 | |||||
Commitments and contingencies | |||||||
Stockholders' equity | |||||||
Preferred stock, $.01 par value; 50,000 shares authorized; none issued and outstanding | — | — | |||||
Common stock, $.01 par value; 300,000 shares authorized; 151,605 and 150,457 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively | 1,516 | 1,505 | |||||
Additional paid-in capital | 3,999,060 | 3,972,917 | |||||
Accumulated other comprehensive loss | (3,736 | ) | (9,981 | ) | |||
Cumulative net income attributable to common stockholders | 1,308,385 | 1,266,158 | |||||
Cumulative dividends | (3,092,343 | ) | (3,045,483 | ) | |||
Total stockholders' equity | 2,212,882 | 2,185,116 | |||||
Total liabilities and stockholders' equity |
- The Consolidated Balance Sheets do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.
Consolidated Statements of Income 1 |
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA |
THREE MONTHS ENDED MARCH 31, | ||||||
2022 | 2021 | |||||
Revenues | ||||||
Rental income | ||||||
Interest from financing receivables, net | 1,930 | — | ||||
Other operating | 2,475 | 1,950 | ||||
142,894 | 130,339 | |||||
Expenses | ||||||
Property operating | 57,464 | 52,215 | ||||
General and administrative | 11,036 | 8,499 | ||||
Acquisition and pursuit costs | 1,303 | 744 | ||||
Merger-related costs | 6,116 | — | ||||
Depreciation and amortization | 54,041 | 50,079 | ||||
129,960 | 111,537 | |||||
Other income (expense) | ||||||
Gain on sales of real estate assets | 44,784 | 18,890 | ||||
Interest expense | (13,661 | ) | (13,262 | ) | ||
Loss on extinguishment of debt | (1,429 | ) | — | |||
Impairment of real estate assets | 25 | (834 | ) | |||
Equity loss from unconsolidated joint ventures | (345 | ) | (74 | ) | ||
Interest and other income (expense), net | (81 | ) | 500 | |||
29,293 | 5,220 | |||||
Net Income | ||||||
Basic earnings per common share - Net income | ||||||
Diluted earnings per common share - Net income | ||||||
Weighted average common shares outstanding - basic | 148,963 | 138,774 | ||||
Weighted average common shares outstanding - diluted | 149,051 | 138,871 |
- The Consolidated Statements of Income do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.
Reconciliation of FFO, Normalized FFO and FAD |
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED |
THREE MONTHS ENDED MARCH 31, | ||||||
2022 | 2021 | |||||
Net income | ||||||
(Gain) on sales of real estate assets | (44,784 | ) | (18,890 | ) | ||
Impairment of real estate asset | (25 | ) | 834 | |||
Real estate depreciation and amortization | 55,658 | 51,311 | ||||
Unconsolidated JV depreciation and amortization | 2,369 | 813 | ||||
Funds from operations (FFO) | ||||||
Acquisition and pursuit costs 1 | 1,303 | 744 | ||||
Merger-related costs | 6,116 | — | ||||
Lease intangible amortization | 309 | (72 | ) | |||
Non-routine legal costs/forfeited earnest money received 2 | 91 | (500 | ) | |||
Debt financing costs | 1,429 | — | ||||
Unconsolidated JV normalizing items | 95 | 27 | ||||
Normalized FFO | ||||||
Non-real estate depreciation and amortization | 460 | 673 | ||||
Non-cash interest amortization 3 | 711 | 894 | ||||
Provision for bad debt, net | 143 | (79 | ) | |||
Straight-line rent income, net | (1,209 | ) | (1,094 | ) | ||
Stock-based compensation | 3,699 | 3,019 | ||||
Unconsolidated JV non-cash items | (271 | ) | (357 | ) | ||
Normalized FFO adjusted for non-cash items | 68,321 | 61,345 | ||||
2nd generation TI | (4,899 | ) | (5,189 | ) | ||
Leasing commissions paid | (3,767 | ) | (1,193 | ) | ||
Capital additions | (2,620 | ) | (2,019 | ) | ||
Maintenance cap ex | (11,286 | ) | (8,401 | ) | ||
Funds available for distribution (FAD) | ||||||
FFO per common share - diluted | ||||||
Normalized FFO per common share - diluted | ||||||
FFO weighted average common shares outstanding - diluted 4 | 149,856 | 139,714 |
- Acquisition and pursuit costs include third party and travel costs related to the pursuit of acquisitions and developments.
- In 2022, the Company recorded non-routine legal costs related to disputes with a contractor and a tenant on a violation of use restrictions. In 2021, the Company recorded forfeited earnest money received related to a disposition that did not materialize.
- Includes the amortization of deferred financing costs and discounts and premiums.
- The Company utilizes the treasury stock method which includes the dilutive effect of nonvested share-based awards outstanding of 804,415 for the three months ended March 31, 2022.
Reconciliation of Non-GAAP Measures |
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED |
Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.
The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.
FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and provision for bad debts, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.
Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.
Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income and less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.
Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.
The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures. These properties are described in additional detail in Footnote 6 to the Condensed Consolidated Financial Statements.
Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion.
Corporate Communications
P: 615.269.8175
FAQ
What were Healthcare Realty Trust's Q1 2022 earnings?
How much did Healthcare Realty Trust acquire in medical office buildings in Q1 2022?
What was the normalized FFO per share for Healthcare Realty Trust in Q1 2022?
What is the tenant retention rate for Healthcare Realty Trust?
What is the dividend payment for Healthcare Realty Trust in Q2 2022?